Possible role of the HMGB1 and RAGE inflammatory pathway in primary sclerosing cholangitis [0.03%]
HMGB1和RAGE炎症途径在原发性硬化性胆管炎中可能的作用
Sander Julia,Sauer Peter,Weiss Karl-Heinz et al.
Sander Julia et al.
Background: Activation of the receptor for advanced glycation end products (RAGE) and its ligand High Mobility Group Box Protein 1 (HMGB1), a nuclear protein with proinflammatory properties, has been implicated in several...
The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis [0.03%]
氟尿嘧啶为基础的辅助治疗对切除胆道癌的有效性和安全性：系统回顾和meta分析
Shaoming Song,Wenwen Yang,Hongwei Tian et al.
Shaoming Song et al.
Objectives: The adjuvant therapy (AT) for biliary tract cancer (BTC) patients after surgery has always been controversial. More therapeutic regimens and high-quality evidence were needed to evaluate AT's survival benefit ...
Boyu Ma,Cuiwei Zhang,Li Jiang et al.
Boyu Ma et al.
Adult diffuse hepatic hemangiomatosis: A case report and review of the literature [0.03%]
成人弥漫性肝海绵状血管瘤病一例并文献复习
Shihua He,Wenjing Chen,Ying Yang et al.
Shihua He et al.
Diffuse hepatic hemangiomatosis (DHH) is an extremely rare disease, especially in adults. We present a case of DHH involving the entire liver in a 62-year-old male with a giant hemangioma next to the superior mesenteric vein. Based on what ...
Transjugular extrahepatic portosystemic shunt (TEPS) creation in patients with complete occlusion of portal vein: Primary experience in a single medical center [0.03%]
经颈静脉肝内门体分流术(TIPS)治疗完全性门静脉闭塞患者的初步经验
Linlin Wang,Yao Peng,Yun Qian et al.
Linlin Wang et al.
Portal hypertension, advanced hepatocellular carcinoma and therapy by atezolizumab-bevacizumab: A "menage à trois" ! [0.03%]
门脉高压、晚期肝细胞癌与阿特珠单抗-贝伐珠单抗治疗：一对三！
Bertille Campion,Edouard Larrey,Mathilde Wagner et al.
Bertille Campion et al.
ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy [0.03%]
肝硬化和肝性脑病大鼠ATP结合盒转运蛋白的表达
Charlotte Bouzbib,Haquima El Mourabit,Dominique Wendum et al.
Charlotte Bouzbib et al.
Background: Pathophysiology of acute encephalopathy in cirrhotic patients is not completely understood. Factors implicated include ammonia, inflammation, various metabolic disorders and drug toxicity. Recent studies have ...
Advances in cell death - related signaling pathways in acute-on-chronic liver failure [0.03%]
细胞死亡在急性-on-慢性肝功能衰竭中的进展及相关信号通路研究 advancements in cell death - related signaling pathways in acute-on-chronic liver failure
Liqiao Huang,Jie Liu,Caiqun Bie et al.
Liqiao Huang et al.
Acute-on-chronic liver failure (ACLF) has been a hot spot in the field of liver disease research in recent years, with high morbidity, rapid course change and high mortality. Currently, there is the absence of specific treatment in clinical...
Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials [0.03%]
拉唑替肽acetate治疗乳糜泻：随机对照试验的系统综述和meta分析
Gilles Jadd Hoilat,Abdulaziz Khalaf Altowairqi,Mohamad Fekredeen Ayas et al.
Gilles Jadd Hoilat et al.
Purpose: The standard of care for treatment of celiac disease (CD) is a stringent lifetime gluten-free diet (GFD). Larazotide acetate (AT-1001) is an anti-zonulin which functions as a gut permeability regulator for treatm...
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports [0.03%]
对于肝癌桥接手术的TACE联合PD-1抑制剂（卡瑞利珠单抗）治疗：个案报道
Haibei Xin,Cunzhen Zhang,Zhiwen Ding et al.
Haibei Xin et al.